Patients with double/triple copy number gains on C-MYC, BCL2, and/or BCL6 treated with standard chemotherapy have a similarly poor prognosis than those with high-grade B cell lymphoma with C-MYC and BCL2 and/or BCL6 rearrangements: a single-center experience on a consecutive cohort of large B cell lymphomas

High-grade B cell lymphomas with rearrangements on C-MYC and BCL2 and/or BCL6 (HGBL with MYC and BCL2 and/or Bcl6 rearrangement) are associated with worse clinical outcomes and thus were introduced as a separate new category in the recently updated WHO classification. From 2012 to 2016, we analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Willenbacher, Ella, Willenbacher, Wolfgang, Weger, Roman, Dominik, Wolf, Manzl, Claudia, Brunner, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419349/
https://www.ncbi.nlm.nih.gov/pubmed/32613279
http://dx.doi.org/10.1007/s00277-020-04124-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7419349/
https://www.ncbi.nlm.nih.gov/pubmed/32613279
http://dx.doi.org/10.1007/s00277-020-04124-0

Ejemplares similares